SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

PME Pro Medicus Limited

Healthcare · Health Information Services · website · 153 employees
$156.38
52wk 107.75 – 316.26
Overall
69.0
Value
2.1
Growth
98.4
Health
100.0
Quality
100.0
Momentum
46.8
Dividend
—
Price
About Pro Medicus Limited

Pro Medicus Limited, a healthcare informatics company, provides medical imaging software and services to hospitals, imaging centers, and health care groups in Australia, Europe, and North America. The company offers Visage RIS, an enterprise-class radiology information system for patient registration, billing, scheduling, typing, HL7 integration, financial reporting, picture archive and communication system (PACS) integration, digital dictation, and voice recognition integration; and Visage RIS/PACS, a solution for imaging needs of organizations. It also provides Visage 7 Enterprise Imaging Platform, a healthcare imaging software for radiologists, physicians, and clinicians for access and visualization capability comprising rapidly viewing 2-D, 3-D, and 4-D medical images, as well as PACS, digital imaging software, training, installation, and professional services and support products; and Visage Ease, a native mobile application for access to medical imaging results stored on a Visage 7 server from iOS devices, including iPad, iPhone, and iTouch. In addition, the company offers Visage Ease Pro for interpreting diagnostic imaging studies; and Promedicus.net, an e-health offering. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Price analytics

Returns

1 day -2.9%
1 week -2.9%
1 month -9.4%
3 months -25.8%
6 months 18.4%
1 year -48.6%
3 years 88.7%

Risk

Volatility (1y ann.) 54.1%
Beta vs ASX 200 1.17
Sharpe (1y) -1.02
VaR 95% (1-day) -4.4%
Max drawdown (1y) -64.6%
Off 1-year high -48.8%

Technicals

RSI(14) 34
vs 50DMA -9.7%
vs 200DMA -3.7%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 2.1
Trailing P/E
0
Forward P/E
0
PEG ratio
13
EV / EBITDA
0
Price / Book
0
Price / Sales
0
Growth 98.4
Revenue growth (1y)
94
Revenue CAGR (3y)
100
EPS growth (1y)
100
EPS CAGR (3y)
100
Financial Health 100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 100.0
Return on equity
100
Return on assets
100
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 46.8
6-month return vs ASX 200
100
Price vs 200-day average
38
Price vs 50-day average
2
Position in 52-week range
23

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$16.34B
P/E (trailing)
61.81
P/E (forward)
68.51
EPS (trailing)
2.53
Dividend yield
0.4%
Payout ratio
24.5%
Beta
0.58
EV / EBITDA
81.87
Price / Book
36.23
ROE
75.0%
Operating margin
77.0%
Net margin
101.4%
Total cash
$252.28M
Total debt
$2.23M
Current ratio
6.85
Debt / Equity
0.00
Free cash flow
$98.87M
Avg volume
234,798
Latest annual results (FY ending 30 Jun 2026)
  • Revenue$261.62M
  • Gross profit$261.21M
  • Operating income$196.04M
  • Net income$265.34M
  • Diluted EPS2.54
  • Free cash flow$118.80M
  • Net debt-$213.90M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4
ANN $6.27B 21.3 71.5